Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Cutting Edge: Amelioration of Kidney Disease in a Transgenic Mouse Model of Lupus Nephritis by Administration of the Caspase Inhibitor Carbobenzoxy-Valyl-Alanyl-Aspartyl-( -o-methyl)-Fluoromethylketone, The Journal of Immunology, September 2001, The American Association of Immunologists,
DOI: 10.4049/jimmunol.167.5.2452.
You can read the full text:

Read

Contributors

The following have contributed to this page